REVIEW
|
doi:10.20944/preprints201810.0577.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
myeloma; daratumumab; elotuzumab; isatuximab; CD38; JNJ- 63723283; denosumab; checkpoint inhibitors; BCMA; bispecific T-cell engager; antibody-drug conjugates
Online: 24 October 2018 (12:11:23 CEST)
REVIEW
|
doi:10.20944/preprints202007.0041.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Multiple myeloma; myeloma bone disease; pathophysiology; osteolysis; imaging; zoledronic acid; denosumab; vertebral augmentation; rehabilitation; exercise
Online: 5 July 2020 (04:19:18 CEST)